Keywords: Elan, Cambridge University, UK research center, Alzheimer's Parkinson's disease

Elan links with Cambridge University for neurological drug research

Article | 29 November 2011

Print This

Ireland-based neuroscience focused biotechnology company Elan Corp (NYSE: ELN) and the UK’s University of Cambridge have announced plans ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in